These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37146537)

  • 21. Clozapine administered once versus twice daily: does it make a difference?
    Procyshyn RM; Vila-Rodriguez F; Honer WG; Barr AM
    Med Hypotheses; 2014 Feb; 82(2):225-8. PubMed ID: 24360486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence.
    Man WH; Pérez-Pitarch A; Wilting I; Heerdink ER; van Solinge WW; Egberts ACG; Huitema ADR
    Br J Clin Pharmacol; 2018 Jun; 84(6):1228-1237. PubMed ID: 29427293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data.
    Ben-Aryeh H; Jungerman T; Szargel R; Klein E; Laufer D
    Biol Psychiatry; 1996 Jun; 39(11):946-9. PubMed ID: 9162206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of clozapine in serum of patients with schizophrenia as a measurement of medication compliance.
    Mennickent S; Sobarzo A; Vega M; de Diego M; Godoy G; Rioseco P; Saavedra L
    Int J Psychiatry Clin Pract; 2010 Mar; 14(1):41-6. PubMed ID: 24917231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to clozapine vs. other antipsychotics in schizophrenia.
    Takeuchi H; Borlido C; Sanches M; Teo C; Harber L; Agid O; Remington G
    Acta Psychiatr Scand; 2020 Aug; 142(2):87-95. PubMed ID: 32627168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will routine therapeutic drug monitoring have a place in clozapine therapy?
    Freeman DJ; Oyewumi LK
    Clin Pharmacokinet; 1997 Feb; 32(2):93-100. PubMed ID: 9068925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine: key discussion points for prescribers.
    Hill M; Freudenreich O
    Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):177-85. PubMed ID: 23302447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine in the treatment of refractory schizophrenia: Canadian policies and clinical guidelines.
    Collins EJ; Lalonde P; Jones BD; Addington D; MacCrimmon DJ; MacEwan GW; Teehan MD
    Can J Psychiatry; 1992 Sep; 37(7):482-96. PubMed ID: 1423146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum level of clozapine and relapse.
    Ulrich S; Wolf R; Staedt J
    Ther Drug Monit; 2003 Apr; 25(2):252-5. PubMed ID: 12657924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Flexible Microfluidic Chip-Based Universal Fully Integrated Nanoelectronic System with Point-of-Care Raw Sweat, Tears, or Saliva Glucose Monitoring for Potential Noninvasive Glucose Management.
    Sun M; Pei X; Xin T; Liu J; Ma C; Cao M; Zhou M
    Anal Chem; 2022 Jan; 94(3):1890-1900. PubMed ID: 35006672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.
    Hutchinson L; Sinclair M; Reid B; Burnett K; Callan B
    Br J Clin Pharmacol; 2018 Jun; 84(6):1089-1108. PubMed ID: 29442362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine treatment: Ensuring ongoing monitoring during the COVID-19 pandemic.
    Nystazaki M; Alevizopoulos G
    Psychiatriki; 2021 Jul; 32(2):165-166. PubMed ID: 33759812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial.
    Szegedi A; Anghelescu I; Wiesner J; Schlegel S; Weigmann H; Härtter S; Hiemke C; Wetzel H
    Pharmacopsychiatry; 1999 Jul; 32(4):148-53. PubMed ID: 10505485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
    McEvoy JP; Lieberman JA; Stroup TS; Davis SM; Meltzer HY; Rosenheck RA; Swartz MS; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK;
    Am J Psychiatry; 2006 Apr; 163(4):600-10. PubMed ID: 16585434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine Response in Schizophrenia and Hematological Changes.
    Blackman G; Lisshammar JEL; Zafar R; Pollak TA; Pritchard M; Cullen AE; Rogers J; Carter B; Griffiths K; Nour M; David AS; McGuire P; Stewart R; MacCabe J
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):19-24. PubMed ID: 33347018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes for clozapine monitoring in the United States.
    Bastiampillai T; Gupta A; Chan SK; Allison S
    Mol Psychiatry; 2016 Jul; 21(7):858-60. PubMed ID: 27137744
    [No Abstract]   [Full Text] [Related]  

  • 39. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR; Leeson VC; Paton C; Marston L; Davies L; Whittaker W; Osborn D; Kumar R; Keown P; Zafar R; Iqbal K; Singh V; Fridrich P; Fitzgerald Z; Bagalkote H; Haddad PM; Husni M; Amos T
    Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Novel Immunoassay With Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) for Therapeutic Drug Monitoring of Clozapine.
    Buckley T; Kitchen C; Vyas G; Siegfried NA; Tefera E; Chen S; DiPaula BA; Kelly DL
    Ther Drug Monit; 2020 Oct; 42(5):771-777. PubMed ID: 32569062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.